Home > PJ (current issue) > The Society / Daily News | Search

The Pharmaceutical Journal
Vol 272 No 7295 p485
17 April 2004


Society summary


Leading speakers confirmed for BPC 2004

Expert speakers from academia, industry, the health professions, the NHS, patient groups and government and acknowledged experts in their fields of research in the pharmaceutical sciences and practice will address the British Pharmaceutical Conference 2004, the Royal Pharmaceutical Society has announced.

This year’s conference takes place at Manchester International Convention Centre from Monday 27 September to Wednesday 29 September.

The conference theme this year is “Medicines: from cell to society”. Speakers who will address the conference on topics related to the theme will include the following:

Monday 27 September
· Sir Nigel Crisp, chief executive of the NHS
· Professor Sandy Florence, University of London School of Pharmacy
· Professor Rob Horne, University of Brighton
· Chris Town, Vice-Chairman of the NHS Confederation negotiation team and Modernisation Agency implementation lead

Tuesday 28 September
· Professor Sir Harry Kroto, Nobel Laureate, University of Sussex
· Dr Jim Smith, Chief Pharmaceutical Officer for England
· Carwen Wynne Howells, Chief Pharmaceutical Adviser for Wales
· Bill Scott, Chief Pharmaceutical Officer for Scotland
· Professor William Dawson, Bionet
· Dr Jean-Yves Maillard, University of Brighton
· Mike King, head of professional development and local pharmaceutical committee Services, Pharmaceutical Services Negotiating Committee

Wednesday 29 September
· Professor Judah Folkman, Harvard Medical School, Boston, US
· Harry Cayton, Director for the Patient and Public Experience

The science programme is developed by the Conference Science Chairman, Professor Ruth Duncan and the Academy of Pharmaceutical Sciences.

New for BPC 2004 is a special day rate of £5 + VAT available for MPharm fourth-year students and preregistration trainees attending the conference on Wednesday 29 September. On the Wednesday morning, student delegates will be able to attend conference scientific and practice sessions and in the afternoon a special session will be held reviewing career opportunities.

Also new this year is the opportunity for university spin-out companies and other research and development-focused small and medium enterprises to showcase innovation and allied technologies and present their latest technology and service offerings alongside the main symposium sessions.

Wally Dove, chairman of the Conference Committee, said: “We are committed to continuously grow and improve the conference and this year’s programme will include sessions of interest to all, for both pharmaceutical science and practice.”

Mr Dove added: “I am pleased that once again Boots The Chemists will be the overall lead sponsor for BPC 2004.”

The programme and booking form are available via the events section of the Society’s website (www.rpsgb.org/events) or by contacting the conference organiser, Health Links (tel 0121 248 3399; e-mail alyons@health-links.fsnet.co.uk).

 

Back to Top


©The Pharmaceutical Journal